Rephonic
Artwork for The Pharma Closeout

The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes

BZ Group
Novo Nordisk
FDA
Lilly
Astrazeneca
Merck & Co.
Novartis
Pfizer
Bristol Myers Squibb
Gilead Sciences
Abbvie
Eli Lilly
GSK
Moderna
Regeneron
Replimune
Roche
Gilead
Glp-1
Artificial Intelligence In Pharma
Capricor Therapeutics

Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Sma... more

PublishesDailyEpisodes198Founded8 months ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for The Pharma Closeout

Latest Episodes

November 1, 2026 edition — delayed release. This recap covers October 26–30; its dated week-ahead items reflect preparation-time previews, not subsequently reported results. The FDA removed the cardiovascular disease, breast cancer and probable demen... more

The Pharma Closeout's ESMO 2026 Debrief brings you the readouts from the European Society for Medical Oncology congress in Madrid that matter, what they change, and what to watch next, with one thread running through them: how much checkpoint therapy... more

October 30 edition — delayed release on November 1. References to today and Friday in the audio refer to October 30.

Acumen ends sabirnetug after a Phase 2 Alzheimer's trial lowered amyloid but missed on cognition and function, and Inovio's Voceryq ... more

October 29, 2026 edition, released October 30. The audio reflects the October 29 roundup; the INO-3107 watch refers to an October 30 FDA target date, not an announced decision.

Iovance's lifileucel produced responses in 17 of 69 previously treated n... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Pharma and BioTech Daily
Pharma and BioTech DailyPharma and BioTech News
WSJ What’s News
WSJ What’s NewsThe Wall Street Journal

Recent Guests

Marcus Webb
On-air guest providing analysis on the Abogen-Novartis deal
Episode: Daily Roundup | Jaypirca Adds a First-Line CLL Choice & Novartis Signs $575M Abogen License
Heidi Overton
President's nominee to run the FDA, physician with Hopkins doctorate
U.S. FDA (nominee)
Episode: Daily Roundup | Heidi Overton FDA Pick: What It Means for Approvals
Nana Loonborg
Forbeon's analyst/commentator referenced in discussion
Forbeon
Episode: Jun 04, 2026 | SCOTUS Backs Hikma Skinny-Label Win on Vascepa; ADC Therapeutics Crashes 50% on Death

Hosts

Alex Mercer
AI-created presenter covering pharmaceutical and biotech news.
Maya Patel
AI-created presenter covering pharmaceutical and biotech news.

Reviews

3.2 out of 5 stars from 12 ratings
  • AI voices are terrible

    The robot readers do not pronounce things correctly and do pauses where they don’t belong making this nearly unlistenable.

    Apple Podcasts
    1
    Adrian8765
    United States2 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

One reviewer says the AI voices mispronounce terms and use awkward pauses, making the audio difficult to listen to.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Daily Roundup | Anktiva Expands Bladder Cancer Label & Vanda's Anxiety Trial Misses
Q: Maya, what did it actually put them through?
Participants took one dose of VQW-765 or placebo, prepared and delivered a presentation to an unresponsive panel, and rated their distress while speaking. The trial's results were not statistically significant.
Daily Roundup | Anktiva Expands Bladder Cancer Label & Vanda's Anxiety Trial Misses
Q: Maya, does that make a randomized trial like Sunrise 5 less valuable?
No. The FDA's extrapolation applies evidence from carcinoma in situ to papillary-only disease, while a randomized trial directly compares treatments in papillary-only patients and can inform choices between options.
Mar 31, 2026 | Lilly's $7.8B Centessa Deal; Biogen Buys Apellis for $5.6B; FDA Flags Tavneos Deaths | Mar 31, 2026
Q: What does the CVR signal tell you about Lilly's deal structure?
It signals that Lilly is pricing in clinical uncertainty and tying part of the economics to milestones, effectively sharing downside risk with the seller while keeping upside tied to future performance.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Pharma Closeout

What is The Pharma Closeout about and what kind of topics does it cover?

Weekday briefings and a Sunday review track pharmaceutical and biotech developments, with a focus on FDA decisions, clinical trial results, drug pipelines, licensing, acquisitions, and financing. Alex Mercer and Maya Patel explain what new evidence shows, where its limitations lie, and what it could mean for patients, regulators, companies, and investors. Coverage spans therapeutic areas from oncology, eye disease, and neuroscience to metabolic and rare diseases, alongside healthcare policy and market developments. The concise format is built for professionals who need frequent, evidence-focused updates without a long discussion. A distinctive emphasis is placed on separating established results from preliminary findings, company claims, an... more

Where can I find podcast stats for The Pharma Closeout?

Rephonic provides a wide range of podcast stats for The Pharma Closeout. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Pharma Closeout and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Pharma Closeout get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The Pharma Closeout, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Pharma Closeout?

Rephonic provides comprehensive predictive audience data for The Pharma Closeout, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Pharma Closeout have?

To see how many followers or subscribers The Pharma Closeout has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Pharma Closeout?

These podcasts share a similar audience with The Pharma Closeout:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. Pharma and BioTech Daily
5. WSJ What’s News

How many episodes of The Pharma Closeout are there?

The Pharma Closeout launched 8 months ago and published 198 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Pharma Closeout?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Pharma Closeout?

Rephonic pulls ratings and reviews for The Pharma Closeout from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Pharma Closeout?

Rephonic provides full transcripts for episodes of The Pharma Closeout. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Pharma Closeout?

Recent guests on The Pharma Closeout include:

1. Marcus Webb
2. Heidi Overton
3. Nana Loonborg

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days